Tag

Insulet Corp

1 article

JPMorgan Cuts Insulet Target 45% to $152

JPMorgan downgraded Insulet to Neutral from Overweight, cutting price target by 45% to $152 from $275. The bank lowered its 2027 revenue forecast 7.6% to $3.67 billion and adjusted EPS estimate 8.8% t